2-Amino-4-methyl-oxazole-5-carboxylic acid methyl ester, 95.0%, 5g

N,N-Dimethyl-4-nitrobenzenesulfonamide, 98%, 10g

1-Iodo-4-methoxy-2-(trifluoromethyl)benzene, 98%, 250mg

rel-(3aR,12bR)-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one, 97%, 250mg

Cold circulation thermostat, 20 °C, 240 W, -10 to +100 °C, 6 lC 100-A10, 1 piece

Spiro[cyclopropane-1,3'-indoline] hydrochloride, 95.0%, 1g

6'-BROMOSPIRO[CYCLOHEXANE-1,2'-INDENE]-1',4(3'H)-DIONE, 95.0%, 250mg

1-(Diphenylmethyl)-3-(hydroxymethyl)azetidine, 95.0%, 25g

2-Bromopyrimidin-5-ol, 95.0%, 25g

2-(3-Fluoro-4-methoxyphenyl)acetamide, 95%, 500mg

1-Methyl-5-nitro-1H-benzo[d]imidazole, 98%, 1g

Plan Fluarex PLFi 4x/0.13 IOS infinity corrected objective. Working distance 16.3 mm

methyl 3-(1H-indol-1-yl)-3-oxopropanoate, 1g